Evaluating decision aids for patients with renal cell carcinoma
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
St. Antonius Hospital · NCT05548621
This study is testing two decision aids to see if they can help patients with renal cell carcinoma make better treatment choices and feel more confident about their decisions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 180 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | St. Antonius Hospital (other) |
| Drugs / interventions | immunotherapy |
| Locations | 1 site (Nieuwegein, Utrecht) |
| Trial ID | NCT05548621 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the impact of two decision aids designed for patients with renal cell carcinoma (RCC) on their decision-making process and the quality of their treatment choices. The decision aids will provide detailed information about treatment options, including potential benefits and side effects, to help patients make informed decisions aligned with their values. The study focuses on patients with either local or metastatic RCC who are facing treatment decisions. By implementing these aids, the study seeks to enhance patient knowledge, reduce anxiety, and improve overall health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are patients clinically diagnosed with renal cell carcinoma who are facing treatment decisions related to their condition.
Not a fit: Patients who are unable to complete questionnaires or participate in interviews individually may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could empower patients with RCC to make more informed treatment decisions, leading to better alignment of care with their personal values and preferences.
How similar studies have performed: Previous studies have shown that decision aids can significantly improve patient outcomes and decision-making processes, indicating a promising approach in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients clinically diagnosed with RCC * Patients facing a decision which is addressed in the decision aids (T1 tumor or metastatic disease) * Written informed consent Exclusion Criteria: * Patients who are not able to fill in a questionnaire or undergo an interview individually
Where this trial is running
Nieuwegein, Utrecht
- St. Antonius Ziekenhuis — Nieuwegein, Utrecht, Netherlands (RECRUITING)
Study contacts
- Study coordinator: Cato Bresser
- Email: c.bresser@antoniusziekenhuis.nl
- Phone: 0631143301
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Renal Cell Carcinoma, Renal Cell Carcinoma Metastatic, decision aid, renal cell carcinoma